Edris Badreddin — SEC Form 4 filings
SEC reporting owner CIK 1786966. 12 Form 4 filings on record with FilingPulse; latest filed 2026-06-16.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-06-05 to 2026-06-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 19 legs across 6 filings — 225,471 shares, $8,531,516 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: sale of 66,477 shares @ $29.44 ($1,957,083) in Edgewise Therapeutics, Inc., filed 2026-01-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SpringWorks Therapeutics, Inc. (SWTX) | Chief Operating Officer | 8 | — | 14 legs · 110,000 sh · $5,132,049 | 13 |
| Edgewise Therapeutics, Inc. (EWTX) | Director | 4 | — | 5 legs · 115,471 sh · $3,399,466 | 14 |
Form 4 filings — Edris Badreddin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-16 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 5,619 (derivative) @ $0 · Grant/award (A): 8,188 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Option exercise (M): 13,690 @ $0.39 · Option exercise (M): 17,236 @ $0.64 · Option exercise (M): 10,463 @ $1.93 · Option exercise (M): 66,477 @ $1.93 · Option exercise (M): 7,605 @ $0.71 · Sale (S): 13,690 @ $29.44 · +9 more | EDGAR |
| 2025-07-02 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Disposition to issuer (D): 169,712 · Disposition to issuer (D): 33,778 (derivative) · Disposition to issuer (D): 3,868 (derivative) · Disposition to issuer (D): 149,470 (derivative) · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 240,000 (derivative) · +2 more | EDGAR |
| 2025-06-18 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Sale (S): 3,924 @ $53.12 · Sale (S): 12,078 @ $54.26 · Sale (S): 3,598 @ $55.12 · Sale (S): 400 @ $56.20 | EDGAR |
| 2025-02-12 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Sale (S): 30,000 @ $53.13 | EDGAR |
| 2025-01-14 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Grant/award (A): 27,023 @ $0 · Grant/award (A): 78,960 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Tax withholding (F): 6,934 @ $38.19 · Tax withholding (F): 5,561 @ $38.19 · Tax withholding (F): 4,416 @ $38.86 | EDGAR |
| 2024-12-05 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Sale (S): 11,966 @ $41.78 · Sale (S): 8,034 @ $42.24 | EDGAR |
| 2024-09-04 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Sale (S): 12,300 @ $40.11 · Sale (S): 4,620 @ $41.12 · Sale (S): 3,080 @ $42.08 | EDGAR |
| 2024-06-12 | 4 | Edgewise Therapeutics, Inc. (EWTX) | Grant/award (A): 20,594 (derivative) @ $0 | EDGAR |
| 2024-06-05 | 4 | SpringWorks Therapeutics, Inc. (SWTX) | Sale (S): 11,772 @ $39.40 · Sale (S): 4,192 @ $40.62 · Sale (S): 3,651 @ $41.38 · Sale (S): 385 @ $42.04 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1786966 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →